RCKT - Rocket Pharmaceuticals, Inc.

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Rocket Pharmaceuticals GAAP EPS of -$0.64 beats by $0.14
• FDA extends review period for Rocket gene therapy to June 30
• Rocket Pharmaceuticals GAAP EPS of -$0.75 beats by $0.07
• Rocket Pharma gains as Cantor sees $65 price target
• Rocket Pharma nabs FDA priority review for gene therapy
• Biggest stock movers today: Grab Holdings, Workhorse Group, Rocket Pharmaceuticals and more
• Rocket rises as FDA supports accelerated path for gene therapy
• Rocket Pharmaceuticals up 19%, prices $175M equity offering
• Rocket Pharmaceuticals soars on proposed public offering of common stock
• Rocket Pharmaceuticals GAAP EPS of -$0.82 in-line
• Rocket Pharma wins key FDA designations for heart disease candidate
• Rocket Pharma granted priority medicines tag for Danon Disease candidate in EU
• Rocket's gene therapy RP-L301 for rare blood disorder gets FDA regenerative medicine tag
• Rocket stock rises amid data from multiple gene therapy programs
• Rocket Pharma wins FDA nod to start trial for heart disease candidate
• Rocket Pharmaceuticals doesn't have any cash, securities at Silicon Valley Bank
• Rocket Pharmaceuticals GAAP EPS of -$0.92 misses by $0.10
• Rocket rises on FDA regenerative medicine tag for cardiac gene therapy
• Rocket defended after update on Danone Disease candidate
• Rocket Pharma to start pivotal trial for Danon Disease candidate in H1 2023